Takeda registers sale of 19,754 ADSs from RSU vesting

Takeda Pharmaceutical Company Limited is registering the potential sale of 19,754 American Depositary Shares (ADSs), corresponding to vested Restricted Stock Unit Awards.

Rhea-AI Filing Summary

Takeda Pharmaceutical Company Limited is registering the potential sale of 19,754 American Depositary Shares (ADSs), corresponding to vested Restricted Stock Unit Awards. The ADSs were acquired as compensation on July 1, 2026 and are proposed to be sold through Interactive Brokers LLC on the NYSE. The filing indicates an aggregate market value of approximately $123,072.06 for the ADSs covered.

Filing Explained

The filing covers a proposed sale of 19,754 ADSs, not a completed sale or established ownership change.

The July 13, 2026 Form 144 reports securities to be sold: 19,754 Takeda ADSs tied to vested restricted stock unit awards dated July 1, 2026; the filing records a proposed disposition, not a completed sale.

The filing identifies the securities as compensation-related and does not disclose a trading plan.

It provides no sale price or resulting-holdings figure, so proceeds and the filer's post-transaction ownership cannot be sized from this record.

Key Figures

ADSs to be sold: 19,754 ADSs Aggregate market value: $123,072.06 Acquisition date: 07/01/2026 +1 more

4 metrics

ADSs to be sold 19,754 ADSs Proposed sale amount from vested Restricted Stock Unit Awards

Aggregate market value $123,072.06 Approximate value of ADSs covered by the notice

Acquisition date 07/01/2026 Date the Restricted Stock Unit Awards vested and ADSs were acquired

Proposed sale date reference 07/01/2026 Date listed in connection with the ADSs to be sold

Key Terms

American Depositary Shares (ADSs), Restricted Stock Unit Awards, compensation, securities to be sold

4 terms

American Depositary Shares (ADSs) financial

"American Depositary Shares (ADSs) | Interactive Brokers LLC"

A U.S.-listed certificate that stands for a specific number of shares in a non‑U.S. company held by a U.S. bank, making the foreign stock tradable on American exchanges in dollars. Think of it like a local voucher that represents ownership of an overseas product — it lets U.S. investors buy and sell foreign companies without handling foreign currency or foreign brokerage accounts, but it can affect dividends, voting rights, fees, liquidity and exposure to currency and regulatory differences.

Restricted Stock Unit Awards financial

"Restricted Stock Unit Awards - Vested."

Restricted stock unit awards are company promises to deliver a specific number of shares to employees or service providers in the future once conditions—such as staying with the company for a set time or meeting performance targets—are met. They matter to investors because when the promises convert into actual shares they increase the total share count and can reduce earnings per share, while also aligning recipients’ interests with stock performance much like deferred pay that turns into ownership if goals are met.

compensation financial

"19754 | 07/01/2026 | Compensation"

securities to be sold regulatory

"144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Takeda (TAK) disclose in this Form 144 filing?

Takeda discloses a planned sale of 19,754 ADSs acquired from vested Restricted Stock Unit Awards, with an aggregate market value of about $123,072.06, to be sold through Interactive Brokers LLC on the NYSE.

How many Takeda (TAK) ADSs may be sold under this notice?

The notice covers up to 19,754 American Depositary Shares (ADSs). These shares originate from Restricted Stock Unit Awards that vested on July 1, 2026 and are being registered for potential resale.

What is the approximate market value of the Takeda (TAK) ADSs to be sold?

The filing lists an aggregate market value of about $123,072.06 for the ADSs covered. This value reflects the 19,754 ADSs proposed for sale that were received as compensation upon RSU vesting.

How were the Takeda (TAK) ADSs being sold originally acquired?

The ADSs were acquired through Restricted Stock Unit Awards that vested on July 1, 2026. The acquisition method is classified as compensation, indicating an equity-based award rather than an open-market purchase.

Which broker and exchange are involved in the Takeda (TAK) ADS sale?

The filing identifies Interactive Brokers LLC as the broker handling the potential sale of ADSs, with trading to occur on the NYSE. The Form 144 serves as advance notice of these potential transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/13/2026 - 06:24 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002123546
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Takeda Pharmaceutical Company Limited
SEC File Number
Address of Issuer	1-1, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo JAPAN 103-8668
Phone	81-3-3278-2111
Name of Person for Whose Account the Securities are To Be Sold	Nicola Greenway
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Chief Human Resources Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares (ADSs)	Interactive Brokers LLC One Pickwick Plaza Greenwich CT 06830	7348	123072.06	143310556	07/13/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ADSs	07/01/2026	Restricted Stock Unit Awards - Vested.	Takeda Pharmaceutical Company Limited			19754	07/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	07/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Kate Huleatt, by power of attorney, for Nicola Greenway
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)